Immune Co-inhibitory Receptors PD-1, CTLA-4, TIM-3, LAG-3, and TIGIT in Medullary Thyroid Cancers: A Large Cohort Study - Shi, Xiao; Li, Cui-Wei; Tan, Li-Cheng; Wen, Shi-Shuai; Liao, Tian; Zhang, Yan; Chen, Tong-Zhen; Ma, Ben; Yu, Peng-Cheng; Lu, Zhong-Wu; Qu, Ning; Wang, Yu; et al. (The journal of clinical endocrinology and metabolism, 2021)
Keywords: Analysis; Antigens; Apoptosis; Cancer; Cancer therapies; Care and treatment; CD223 antigen; Cell activation; Cell death; CTLA-4 protein; Cytotoxicity; DNA microarrays; Health aspects; Immune response; Immunogenicity; Immunoglobulins; Immunohistochemistry; Immunotherapy; Lymphocytes T; Oncology, Experimental; Patients; PD-1 protein; PD-L1 protein; Proteins; Rankings; T cells; Thyroid cancer; Thyroid carcinoma; Thyroid gland; Vandetanib; China; PD-L1; immune co-inhibitory receptors; CTLA-4; medullary thyroid carcinoma; TIM-3; PD-1